Limited nonclinical cellular kinetics data reported in the literature have shown that i.v. administration of anti-mesothelin and anti-BCMA CAR T cells in tumor bearing NSG mice would lead to a Tmax ranging from 5 to 14 days. This evidence concerns the gene TNFRSF17 and neoplasm.